Clinical efficacy of Fufang Yinhua Jiedu (FFYH) granules in mild COVID-19 and its anti-SARS-CoV-2 mechanism by blocking autophagy through inhibiting the AKT/mTOR signaling pathway

• Main Authors: Wenlei Wang (Author), Zhihui Zheng (Author), Xiaoyuan Qi (Author), Hailin Wei (Author), Xuhua Mao (Author), Qin Su (Author), Xiang Chen (Author), Yan Feng (Author), Guohong Qiao (Author), Tieliang Ma (Author), Zhian Tang (Author), Guangming Zhou (Author), Jinqiang Zhuang (Author), Pinghu Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundFufang Yinhua Jiedu (FFYH) granules are recommended for treating coronavirus pneumonia (COVID-19) in China. However, its anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity and clinical efficacy against COVID-19 remain to be confirmed.AimsOur study aimed to investiga...